These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22076756)

  • 1. A novel approach to cancer therapy using PX-478 as a HIF-1α inhibitor.
    Lee K; Kim HM
    Arch Pharm Res; 2011 Oct; 34(10):1583-5. PubMed ID: 22076756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells.
    Palayoor ST; Mitchell JB; Cerna D; Degraff W; John-Aryankalayil M; Coleman CN
    Int J Cancer; 2008 Nov; 123(10):2430-7. PubMed ID: 18729192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer.
    Schwartz DL; Bankson JA; Lemos R; Lai SY; Thittai AK; He Y; Hostetter G; Demeure MJ; Von Hoff DD; Powis G
    Mol Cancer Ther; 2010 Jul; 9(7):2057-67. PubMed ID: 20587661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha.
    Koh MY; Spivak-Kroizman T; Venturini S; Welsh S; Williams RR; Kirkpatrick DL; Powis G
    Mol Cancer Ther; 2008 Jan; 7(1):90-100. PubMed ID: 18202012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New drugs target hypoxia response in tumors.
    Garber K
    J Natl Cancer Inst; 2005 Aug; 97(15):1112-4. PubMed ID: 16077066
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha.
    Welsh S; Williams R; Kirkpatrick L; Paine-Murrieta G; Powis G
    Mol Cancer Ther; 2004 Mar; 3(3):233-44. PubMed ID: 15026543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo.
    Jordan BF; Black K; Robey IF; Runquist M; Powis G; Gillies RJ
    NMR Biomed; 2005 Nov; 18(7):430-9. PubMed ID: 16206237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.
    Creighton-Gutteridge M; Cardellina JH; Stephen AG; Rapisarda A; Uranchimeg B; Hite K; Denny WA; Shoemaker RH; Melillo G
    Clin Cancer Res; 2007 Feb; 13(3):1010-8. PubMed ID: 17289897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
    Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
    Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
    Patiar S; Harris AL
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects.
    Schwartz DL; Powis G; Thitai-Kumar A; He Y; Bankson J; Williams R; Lemos R; Oh J; Volgin A; Soghomonyan S; Nishii R; Alauddin M; Mukhopadhay U; Peng Z; Bornmann W; Gelovani J
    Mol Cancer Ther; 2009 Apr; 8(4):947-58. PubMed ID: 19372568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting hypoxia-inducible factor 1 for cancer therapy.
    Melillo G
    Mol Cancer Res; 2006 Sep; 4(9):601-5. PubMed ID: 16940159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone inhibits HIF-1α expression in a topoisomerase II-independent pathway.
    Toh YM; Li TK
    Clin Cancer Res; 2011 Aug; 17(15):5026-37. PubMed ID: 21653687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma.
    Shrestha P; Davis DA; Veeranna RP; Carey RF; Viollet C; Yarchoan R
    PLoS Pathog; 2017 Sep; 13(9):e1006628. PubMed ID: 28922425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proresolution effects of hydrogen sulfide during colitis are mediated through hypoxia-inducible factor-1α.
    Flannigan KL; Agbor TA; Motta JP; Ferraz JG; Wang R; Buret AG; Wallace JL
    FASEB J; 2015 Apr; 29(4):1591-602. PubMed ID: 25550470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.
    Jordan BF; Runquist M; Raghunand N; Baker A; Williams R; Kirkpatrick L; Powis G; Gillies RJ
    Neoplasia; 2005 May; 7(5):475-85. PubMed ID: 15967100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noscapine inhibits hypoxia-mediated HIF-1alpha expression andangiogenesis in vitro: a novel function for an old drug.
    Newcomb EW; Lukyanov Y; Schnee T; Ali MA; Lan L; Zagzag D
    Int J Oncol; 2006 May; 28(5):1121-30. PubMed ID: 16596228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
    Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-glucosamine down-regulates HIF-1alpha through inhibition of protein translation in DU145 prostate cancer cells.
    Park JY; Park JW; Suh SI; Baek WK
    Biochem Biophys Res Commun; 2009 Apr; 382(1):96-101. PubMed ID: 19254699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.